USPTO serial 75432734
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Thousand Oaks, CA
Thousand Oaks, CA
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
MARK I FELDMAN
MARK I FELDMAN RUDNICK & WOLFEP O BOX 64807CHICAGO, IL 60664-0807UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations, namely, pharmaceuticals for modulating weight loss, regulating reproductive function, promoting wound healing, and for use in the treatment of obesity, diabetes, hypertension, dyslipidemia, cardiovascular diseases, and infertility | ABANDONED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 16, 1999 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Jul 16, 1999 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jun 23, 1999 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 11, 1999 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Jan 19, 1999 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 18, 1998 | NPUB | NOTICE OF PUBLICATION | — |
| Oct 28, 1998 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 25, 1998 | CNEA | EXAMINER'S AMENDMENT MAILED | — |
| Sep 24, 1998 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 24, 1998 | DOCK | ASSIGNED TO EXAMINER | — |